COVID-19 vaccine hesitancy in Chinese residents: A national cross-sectional survey in the community setting
Creators: name: Zhao, Tianshuo
name: Cai, Xianming
name: Zhang, Sihui
name: Wang, Mingting
name: Chen, Linyi
name: Li, Xikun
name: Wang, Zhuangye
name: Wang, Li
name: Jiang, Wenguo
name: Ha, Yu
name: Li, Hui
name: Liu, Yaqiong
name: Lu, Qingbin
name: Cui, Fuqiang
Publisher: name: Taylor & Francis
Year: 2025
Subjects: subject: Medicine
subject: Biotechnology
subject: Sociology
subject: FOS: Sociology
subject: Immunology
subject: FOS: Clinical medicine
subject: Cancer
subject: Science Policy

description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine hesitancy is associated with community aggregation, inducing low vaccine coverage and potentially more frequent community-level outbreak. Addressing vaccine hesitancy in community settings should be a priority for healthcare providers. A cross-sectional online questionnaire survey was conducted during June and July 2022. Ten sites were set up in eastern, central, and western China, from where residents were recruited in a community setting. In total, 7,241 residents from 71 communities were included. Of the residents, 7.0% had refusal administration, 30.4% had delayed administration, and community clustering accounted for 2.4–3.7% and 8.5–9.6% of the variation, respectively. The reasons for primary-dose refusal were diseases, pregnancy, or lactation, whereas the main reasons for booster-dose refusal were diseases during the vaccination period, no time to vaccinate, and felt unnecessary to vaccinate. Younger age (under 40), female, residing in urban settings and having self-reported diseases were sociodemographic indicators of risk for refusal. In the health belief model of refusing to vaccinate, perceived barriers had a positive impact on refusal (β = 0.08), while perceived benefits had a negative impact (β = -0.09). In conclusion, this study underscores the population heterogeneity and community clustering of SARS-CoV-2 vaccine hesitancy. Targeted interventions for these high-risk groups are crucial to enhance vaccination coverage and prevent outbreaks. Public health strategies should address vaccine hesitancy at different stages and doses, while considering both individual beliefs and community dynamics. Sociodemographic influences: Younger women in urban areas with health conditions were more likely to refuse or delay vaccination.Vaccine hesitancy behaviors in community: We focused on vaccine hesitancy behaviors rather than willingness or confidence, in a large community setting.Clustering of hesitancy: Vaccine hesitancy clustered within communities, with community variation accounting for 2.4%–3.7% for refusal and 8.5%–9.6% for delayed vaccination.Concerns in high-risk groups: We identified a gap between low vaccine acceptance in patients with severe diseases or comorbidities and the prioritization of these groups for vaccination. Sociodemographic influences: Younger women in urban areas with health conditions were more likely to refuse or delay vaccination. Vaccine hesitancy behaviors in community: We focused on vaccine hesitancy behaviors rather than willingness or confidence, in a large community setting. Clustering of hesitancy: Vaccine hesitancy clustered within communities, with community variation accounting for 2.4%–3.7% for refusal and 8.5%–9.6% for delayed vaccination. Concerns in high-risk groups: We identified a gap between low vaccine acceptance in patients with severe diseases or comorbidities and the prioritization of these groups for vaccination.